We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Advertisement
Analytical Cannabis Logo
×
Home > Science & Health

Cannabis Science & Health

Cannabinoid-based R & D to Focus on Tackling the Opioid Crisis

Studies have already shown that phytocannabinoids like cannabidiol have promising results in opioid withdrawal symptoms and heroin-seeking behavior.

Read More

FDA Approves Drug Containing a Cannabis-derived Compound for First Time

Epidiolex contains cannabidiol (CBD) and is the first FDA-approved drug that contains a purified drug substance derived from marijuana.

Read More

Cannabis Oil for Epilepsy – What You Need to Know

A small number of studies have shown that adding cannabis oil to existing medication may be effective in devastating, hard-to-treat epilepsy in children and adolescents.

Read More

Effects of Cannabigerol Revealed for the First Time

These findings reopen the discussion about the ability of other phytocannabinoids, whose mechanism of action was unknown, to bind directly to cannabinoid receptors as Δ 9-THC does.

Read More

Dangers Lurking in Synthetic CBD Underscore Value of Quality Product

The natural healing properties of CBD are being jeopardized by the advent of man-made synthetic CBDs.

Read More

DEA Permits Further Cannabinoid-based Pharma Research

The research is focused on developing a drug that enables patients to benefit from the medicinal benefits of THC without experiencing its inherit psychoactive properties.

Read More

Daily Cannabis Use on the Rise in American Adults

Significant increases in cannabis use among adults 65 and older defy perceptions that older adults do not use cannabis.

Read More

DEA Green-lights Novel Cannabinoid Research

The research will build on previous findings that could enhance the performance of other cancer therapeutics such as checkpoint inhibitors, which activate the immune system to destroy cancer cells.

Read More

Cannabis to be Assessed as an Alternative to Fentanyl in Pivotal Clinical Trial

The trial is designed to assess the time-to-relief in patients suffering from severe pain.

Read More

 
Advertisement